205 related articles for article (PubMed ID: 17305714)
1. Transcriptional regulation by targeted expression of architectural transcription factor high mobility group A2 in salivary glands of transgenic mice.
Lin HH; Xiong Y; Ho YS; Zhou B; Nguyen HV; Deng H; Lee R; Yen Y; Borok Z; Ann DK
Eur J Oral Sci; 2007 Feb; 115(1):30-9. PubMed ID: 17305714
[TBL] [Abstract][Full Text] [Related]
2. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.
Queimado L; Lopes CS; Reis AM
Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of hepatocyte nuclear factor-4alpha and its role in regulation of gene expression by TGF-beta in mammary epithelial cells.
Ishikawa F; Nose K; Shibanuma M
Exp Cell Res; 2008 Jun; 314(10):2131-40. PubMed ID: 18433744
[TBL] [Abstract][Full Text] [Related]
4. Misexpression of full-length HMGA2 induces benign mesenchymal tumors in mice.
Zaidi MR; Okada Y; Chada KK
Cancer Res; 2006 Aug; 66(15):7453-9. PubMed ID: 16885341
[TBL] [Abstract][Full Text] [Related]
5. The Mia/Cd-rap gene expression is downregulated by the high-mobility group A proteins in mouse pituitary adenomas.
De Martino I; Visone R; Palmieri D; Cappabianca P; Chieffi P; Forzati F; Barbieri A; Kruhoffer M; Lombardi G; Fusco A; Fedele M
Endocr Relat Cancer; 2007 Sep; 14(3):875-86. PubMed ID: 17914116
[TBL] [Abstract][Full Text] [Related]
6. High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy.
Pierantoni GM; Finelli P; Valtorta E; Giardino D; Rodeschini O; Esposito F; Losa M; Fusco A; Larizza L
Endocr Relat Cancer; 2005 Dec; 12(4):867-74. PubMed ID: 16322327
[TBL] [Abstract][Full Text] [Related]
7. HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity.
Fedele M; Visone R; De Martino I; Troncone G; Palmieri D; Battista S; Ciarmiello A; Pallante P; Arra C; Melillo RM; Helin K; Croce CM; Fusco A
Cancer Cell; 2006 Jun; 9(6):459-71. PubMed ID: 16766265
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias.
Belge G; Meyer A; Klemke M; Burchardt K; Stern C; Wosniok W; Loeschke S; Bullerdiek J
Genes Chromosomes Cancer; 2008 Jan; 47(1):56-63. PubMed ID: 17943974
[TBL] [Abstract][Full Text] [Related]
9. HMGA2 regulates transcription of the Imp2 gene via an intronic regulatory element in cooperation with nuclear factor-kappaB.
Cleynen I; Brants JR; Peeters K; Deckers R; Debiec-Rychter M; Sciot R; Van de Ven WJ; Petit MM
Mol Cancer Res; 2007 Apr; 5(4):363-72. PubMed ID: 17426251
[TBL] [Abstract][Full Text] [Related]
10. DNA architectural factor and proto-oncogene HMGA2 regulates key developmental genes in pluripotent human embryonic stem cells.
Li O; Li J; Dröge P
FEBS Lett; 2007 Jul; 581(18):3533-7. PubMed ID: 17624332
[TBL] [Abstract][Full Text] [Related]
11. Transactivation functions of the tumor-specific HMGA2/LPP fusion protein are augmented by wild-type HMGA2.
Crombez KR; Vanoirbeek EM; Van de Ven WJ; Petit MM
Mol Cancer Res; 2005 Feb; 3(2):63-70. PubMed ID: 15755872
[TBL] [Abstract][Full Text] [Related]
12. Detection of high-mobility group proteins A1 and A2 represents a valid diagnostic marker in post-pubertal testicular germ cell tumours.
Franco R; Esposito F; Fedele M; Liguori G; Pierantoni GM; Botti G; Tramontano D; Fusco A; Chieffi P
J Pathol; 2008 Jan; 214(1):58-64. PubMed ID: 17935122
[TBL] [Abstract][Full Text] [Related]
13. Identification of the benign mesenchymal tumor gene HMGA2 in lymphangiomyomatosis.
D'Armiento J; Imai K; Schiltz J; Kolesnekova N; Sternberg D; Benson K; Pardo A; Selman M; Smolarek T; Vundavalli M; Sonnet J; Szabolcs M; Chada K
Cancer Res; 2007 Mar; 67(5):1902-9. PubMed ID: 17332316
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family.
Motoyama K; Inoue H; Nakamura Y; Uetake H; Sugihara K; Mori M
Clin Cancer Res; 2008 Apr; 14(8):2334-40. PubMed ID: 18413822
[TBL] [Abstract][Full Text] [Related]
15. HMGA2 overexpression in non-small cell lung cancer.
Meyer B; Loeschke S; Schultze A; Weigel T; Sandkamp M; Goldmann T; Vollmer E; Bullerdiek J
Mol Carcinog; 2007 Jul; 46(7):503-11. PubMed ID: 17477356
[TBL] [Abstract][Full Text] [Related]
16. A promoter element with enhancer properties, and the orphan nuclear receptor RORalpha, are required for Purkinje cell-specific expression of a Gi/o modulator.
Serinagaoglu Y; Zhang R; Zhang Y; Zhang L; Hartt G; Young AP; Oberdick J
Mol Cell Neurosci; 2007 Mar; 34(3):324-42. PubMed ID: 17215137
[TBL] [Abstract][Full Text] [Related]
17. Oligonucleotide microarray analysis of human lens epithelial cells: TGFbeta regulated gene expression.
Dawes LJ; Elliott RM; Reddan JR; Wormstone YM; Wormstone IM
Mol Vis; 2007 Jul; 13():1181-97. PubMed ID: 17679943
[TBL] [Abstract][Full Text] [Related]
18. A microRNA encoded in a highly conserved part of the mammalian HMGA2 gene.
von Ahsen I; Nimzyk R; Klemke M; Bullerdiek J
Cancer Genet Cytogenet; 2008 Nov; 187(1):43-4. PubMed ID: 18992641
[TBL] [Abstract][Full Text] [Related]
19. Microarray screening for target genes of the proto-oncogene PLAG1.
Voz ML; Mathys J; Hensen K; Pendeville H; Van Valckenborgh I; Van Huffel C; Chavez M; Van Damme B; De Moor B; Moreau Y; Van de Ven WJ
Oncogene; 2004 Jan; 23(1):179-91. PubMed ID: 14712223
[TBL] [Abstract][Full Text] [Related]
20. Gene expression analysis of urethane-induced lung tumors in ras H2 mice.
Okamura M; Unami A; Matsumoto M; Oishi Y; Kashida Y; Mitsumori K
Toxicology; 2006 Jan; 217(2-3):129-38. PubMed ID: 16289808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
